CPCA Coding for Facial Injections 5

Question 1

Which of the following best describes the National Correct Coding Initiative (NCCI) edit that most commonly affects facial injection coding?

Accepted Answer

Bundling of the injection code with evaluation and management when a modifier is not applied

Answer

NCCI edits bundle certain procedure codes with E/M services unless Modifier 25 is appended to show a distinct, separately identifiable service.

Question 2

A patient receives masseter botulinum toxin injections for documented temporomandibular joint (TMJ) disorder. Which ICD-10-CM code best supports medical necessity?

Accepted Answer

M26.60 (TMJ disorder, unspecified)

Answer

M26.60 classifies temporomandibular joint disorder and provides medical justification for chemodenervation of the masseter muscle.

Question 3

When reporting botulinum toxin for hyperhidrosis of the face, which CPT code is used?

Accepted Answer

64650

Answer

CPT 64650 covers chemodenervation of eccrine glands for treatment of hyperhidrosis, distinct from muscle-targeted chemodenervation codes.

Question 4

Under Medicare, botulinum toxin injections for cosmetic purposes such as forehead rhytides are classified as:

Accepted Answer

Non-covered services excluded from the Medicare benefit

Answer

Medicare explicitly excludes cosmetic procedures, including botulinum toxin for wrinkles, from coverage as they lack medical necessity.

Question 5

What does the place-of-service (POS) code 11 versus POS 22 indicate on a facial injection claim, and why does it matter?

Accepted Answer

POS 11 (office) vs. POS 22 (on campus outpatient hospital) affects reimbursement rates and facility fee eligibility

Answer

The POS code determines whether a facility fee can be billed separately and affects the applicable fee schedule, which can significantly impact total reimbursement.

CPCA Exam Practice Test

CPCA Exam Practice Test

CPCA Coding for Facial Injections 5